Found: 11
Select item for more details and to access through your institution.
Long-term natalizumab treatment is associated with sustained improvements in quality of life in patients with multiple sclerosis.
- Published in:
- Patient Preference & Adherence, 2017, v. 11, p. 1035, doi. 10.2147/PPA.S134865
- By:
- Publication type:
- Article
Improved patient-reported health impact of multiple sclerosis: The ENABLE study of PR-fampridine.
- Published in:
- Multiple Sclerosis Journal, 2016, v. 22, n. 7, p. 944, doi. 10.1177/1352458515606809
- By:
- Publication type:
- Article
Effects of BG-12 (dimethyl fumarate) on health-related quality of life in patients with relapsing–remitting multiple sclerosis: findings from the CONFIRM study.
- Published in:
- Multiple Sclerosis Journal, 2014, v. 20, n. 2, p. 253, doi. 10.1177/1352458513507818
- By:
- Publication type:
- Article
Quality of life outcomes with BG-12 (dimethyl fumarate) in patients with relapsing–remitting multiple sclerosis: The DEFINE study.
- Published in:
- Multiple Sclerosis Journal, 2014, v. 20, n. 2, p. 243, doi. 10.1177/1352458513507817
- By:
- Publication type:
- Article
Patient Perspective on Acute Intermittent Porphyria with Frequent Attacks: A Disease with Intermittent and Chronic Manifestations.
- Published in:
- Patient, 2018, v. 11, n. 5, p. 527, doi. 10.1007/s40271-018-0319-3
- By:
- Publication type:
- Article
Adherence and persistence among multiple sclerosis patients after one immunomodulatory therapy failure: retrospective claims analysis.
- Published in:
- 2011
- By:
- Publication type:
- Journal Article
Adherence and persistence among multiple sclerosis patients after one immunomodulatory therapy failure: Retrospective claims analysis.
- Published in:
- Advances in Therapy, 2011, v. 28, n. 9, p. 761, doi. 10.1007/s12325-011-0054-9
- By:
- Publication type:
- Article
Impact of adherence to disease-modifying therapies on clinical and economic outcomes among patients with multiple sclerosis.
- Published in:
- Advances in Therapy, 2011, v. 28, n. 1, p. 51, doi. 10.1007/s12325-010-0093-7
- By:
- Publication type:
- Article
Development of the multiple sclerosis (MS) early mobility impairment questionnaire (EMIQ).
- Published in:
- Journal of Neurology, 2016, v. 263, n. 10, p. 1969, doi. 10.1007/s00415-016-8210-4
- By:
- Publication type:
- Article
Impact of natalizumab on patient-reported outcomes in multiple sclerosis: a longitudinal study.
- Published in:
- Health & Quality of Life Outcomes, 2015, v. 10, n. 1, p. 1, doi. 10.1186/1477-7525-10-155
- By:
- Publication type:
- Article
Impact of natalizumab on patient-reported outcomes in multiple sclerosis: a longitudinal study.
- Published in:
- Health & Quality of Life Outcomes, 2012, v. 10, n. 1, p. 155, doi. 10.1186/1477-7525-10-155
- By:
- Publication type:
- Article